Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05564273 · ClinicalTrials.gov registry record · NA
Viome Nutritional Programs to Improve Clinical Outcomes for Metabolic Conditions
A NA study of Metabolic Health, sponsored by Viome.
- Recruiting
- Registry status
- NA
- Development phase
- 150
- Enrollment target
- 1
- Study location
NCT05564273: Recruiting NA study of Metabolic Health, sponsored by Viome.
NCT05564273 is a NA study of Metabolic Health that is actively recruiting participants, run by Viome. The registered enrollment target is 150 participants, below the 50,130-participant average among 10 other Metabolic Health trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05564273, a NA study of Metabolic Health, is actively recruiting participants, sponsored by Viome.
- RECRUITING
- Registry status
- NA
- Development phase
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
US residents who have obesity and sign the informed consent form and are screened and enrolled for this study. Participants who are enrolled complete a survey upon enrollment and are randomized into one of three arms. This study is direct to participant and will not utilize clinical sites.
Primary Outcome
Number of participants that show an improvement in metabolic health compared to baseline survey assessment.
Conditions Studied
Interventions
- COMBINATION_PRODUCT VIOME Precision Nutrition Program
- DIETARY_SUPPLEMENT VIOME-designed condition-based supplements
Study Locations (1)
Washington
- Viome Life Sciences - Bothell
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2023-10-13 |
| Est. Completion | 2026-12 |
| Phase | NA |
What NCT05564273 shows while recruiting
NCT05564273 is an interventional study that assigns participants to a tested intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, below the 50,130-participant average among 10 other Metabolic Health trials with a reported enrollment target (100% lower).
The record links to 1 condition, with Metabolic Health appearing as the primary indexed condition, and to 2 interventions - of which VIOME Precision Nutrition Program is the first listed.
NCT05564273 reports a single indexed study location in Washington.
Frequently Asked Questions
What is clinical trial NCT05564273 about?
NCT05564273 is a clinical study titled "Viome Nutritional Programs to Improve Clinical Outcomes for Metabolic Conditions". US residents who have obesity and sign the informed consent form and are screened and enrolled for this study. Participants who are enrolled complete a survey upon enrollment and are randomized into one of three arms. This study is direct to participant and will not utilize clinical sites.
What is the current status of trial NCT05564273?
This trial is currently recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2023-10-13. Estimated completion is 2026-12.
What conditions does trial NCT05564273 study?
This clinical trial studies the following conditions: Metabolic Health.
What interventions are being tested in trial NCT05564273?
The interventions under investigation include: VIOME Precision Nutrition Program (COMBINATION_PRODUCT), VIOME-designed condition-based supplements (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05564273?
This trial is sponsored by Viome, which has 18 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05564273 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Metabolic Health
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05564273's enrollment target sits among peer trials
150 3rd of 10 higher than 8 of 10 other Metabolic Health trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Metabolic Health trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Women's Hormonal and Metabolic Wellbeing Study
RECRUITING · NA
-
Health, Environment and Action in Louisville (HEAL) Green Heart Louisville Project
RECRUITING · NA
-
Study to Evaluate the Efficacy of an Avocado Dietary Supplement
ACTIVE NOT RECRUITING · NA
-
Impact of Protein Source and Polyphenol Complexation in Protein Bars on Metabolic Health
ACTIVE NOT RECRUITING · NA
-
Effects of a Synbiotic Supplement on Metabolic & Cognitive Outcomes Among Older Adults
COMPLETED · NA
-
Metabolic Health 1: Power Line Evaluation; Effect Size Determination
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI